Skip to main content
. 2016 Oct 8;89(1067):20160247. doi: 10.1259/bjr.20160247

Figure 3.

Figure 3.

Contrast-enhanced multidetector CT scan demonstrating stable disease (SD) after transarterial chemoembolization with drug-eluting beads preloaded with irinotecan according to response evaluation criteria in solid tumour 1.1: pre-treatment (a) arterial and (b) portal-phase CT scans and post-treatment (c) arterial and (d) portal-phase CT scans. The use of modified Response Evaluation Criteria In Solid Tumors (mRECIST) would have revealed a partial response instead of an SD in this case, owing to the high percentage of tumour necrosis (arrows).